Key Ratio
USD
6.8
- (3.2%)
NASDAQ:BVS, BIOVENTUS INC.
Industry: Medical Devices
End of Day: 8 May 2025 GMT-4
Income Statement Ratios
Fiscal
Gross Profit Margin
62.90%
Net Profit Margin (Adj.)
-1.50%
Return on Equity (Adj.)
-58.40%
Fiscal (USD)
Period End Date
Financials
Revenue
Gross Profit
EBITDA
Operating Profit
Net Income (To Shareholders)
Net Income (Adj.)
Ratios
Gross Profit Margin
EBITDA Margin
Operating Margin
Net Profit Margin (Adj.)
Return on Equity (Adj.)
Return on Equity (Adj.) 3Y
Return on Equity (Adj.) 5Y
Return on Assets (Adj.)
Return On Invested Capital (Adj.)
ROIIC 3Y
ROIIC 10Y
Degree Of Op. Leverage (EBIT)
Degree Of Op. Leverage (CFO)
Rule Of 40 (EBITDA)
Rule Of 40 (FCF)
Per Share
Revenue / Share
Operating Profit / Share
Diluted EPS
Diluted EPS (Adj.)
FY22
31 Dec 2022
LTM23 Q3
30 Sep 2023
512
502
331
316
-171
-95.2
-48.6
-25.3
-158
-182
-164
-137
64.6%
62.9%
-33.4%
-18.9%
-46.5%
-33.5%
1%
-1.5%
-38.4%
-58.4%
-8.4%
-20.8%
-0.5%
-14.3%
-10.8%
-13.0%
3.3%
6.0%
-20.4%
-23.0%
-
-
-
-
-
-
-14.6
-21.6
14.0
-3.0
8.3
8.0
-0.8
-0.4
-2.6
-2.9
-2.6
-2.9
In Millions except per share items.
Balance Sheet Ratios
Fiscal
Current Ratio
1.60x
Cash Ratio
0.200x
Total Debt to Equity Ratio
2.20x
Fiscal (USD)
Period End Date
Financials
Short Term Cash Investments
Total Assets
Total Debt
Total Liabilities
Total Equity
Ratios
Current Ratio
Cash Ratio
Total Debt to Equity Ratio
Net Debt (Cash) to Equity
Net Debt (Cash) to NTA
Cash Conversion Cycle
Avg Days Sales Out.
Avg Days Inventory Out.
Avg Days Payables Out.
Per Share
Total Assets / Share
Book Value/Share
Tangible Book Value / Share
Total Debt / Share
Cash / Share
Net Debt (Cash) / Share
FY22
31 Dec 2022
LTM23 Q3
30 Sep 2023
31.8
26.8
1,372
811
418
394
1,032
584
316
177
0.9x
1.6x
0.1x
0.2x
1.3x
2.2x
1.2x
2.1x
-0.5x
-1.1x
186
223
93.2
89.0
148
170
54.9
35.9
22.1
12.9
5.1
2.8
-11.9
-5.1
6.7
6.3
0.5
0.4
6.2
5.8
In Millions except per share items.
Cash Flow Ratios
Fiscal (USD, MM)
Cash From Operations
10.2
CAPEX
-11.9
Free Cash Flow (FCF)
-1.7
Fiscal (USD)
Period End Date
Financials
CFO bef. W.C. Changes
Cash From Operations
CAPEX
Cash Flow From Investing
Cash Flow From Financing
Free Cash Flow (FCF)
Ratios
FCF Margin
Quality Of Earnings
Dividend Payout Ratio
Per Share
Cash From Operations / Share
Free Cash Flow / Share
Dividend / Share
Special Dividend / Share
FY22
31 Dec 2022
LTM23 Q3
30 Sep 2023
-146
-130
-13.5
10.2
-11.5
-11.9
-116
13.0
62.1
-32.1
-25.1
-1.7
-4.9%
-0.3%
-
-
-
-
-0.2
0.2
-0.4
-0.03
-
-
-
-
In Millions except per share items.
Valuation Ratios
Fiscal
Price / Sales
0.40x
Price / Earnings (Adj.)
-1.50x
Price / Tangible Book
-0.60x
Fiscal (USD)
Period End Date
Dividend Yield
Special Dividend Yield
Price / Sales
Price / Earnings (Adj.)
Price / Book
Price / Tangible Book
Price / CFO
Price / FCF
EV / EBIT
FY22
31 Dec 2022
LTM23 Q3
30 Sep 2023
-
-
-
-
0.3x
0.4x
-1x
-1.5x
0.5x
1.2x
-0.2x
-0.6x
-12.0x
20.3x
-6.5x
-125.2x
-10.7x
-23.4x
Other Ratios
Fiscal (USD)
Period End Date
Revenue Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Operating Profit Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Net Income (Adj.) Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Diluted (Adj.) EPS Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Cash From Operations Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Free Cash Flow Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
FY22
31 Dec 2022
LTM23 Q3
30 Sep 2023
18.8%
-2.7%
14.6%
16.2%
10.5%
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-82.2%
-
-22.1%
-
-
-
-
-
-
-
-
-46.7%
-
-
-
-
-
-
-
-
-
-
-
-
Fiscal (USD)
Period End Date
Market Capitalization
Total Enterprise Value
Shares Outstanding
FY22
31 Dec 2022
LTM23 Q3
30 Sep 2023
131.9575m
234.2173m
522.0025m
590.7163m
62.063m
62.9658m
- Figures shown are in its reported currency unless stated otherwise.
- Net Income and its respective ratios are normalised for one-off items unless stated otherwise.
- PR = Press Release
- FYC = Financial Year Change
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
